These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1446142)

  • 1. The effect of GR32191 (a thromboxane receptor antagonist) on airway responsiveness in asthma.
    Stenton SC; Young CA; Harris A; Palmer JB; Hendrick DJ; Walters EH
    Pulm Pharmacol; 1992 Sep; 5(3):199-202. PubMed ID: 1446142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GR32191, a potent thromboxane receptor antagonist, on exercise induced bronchoconstriction in asthma.
    Finnerty JP; Twentyman OP; Harris A; Palmer JB; Holgate ST
    Thorax; 1991 Mar; 46(3):190-2. PubMed ID: 1827543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ineffectiveness of a four week treatment with the thromboxane synthetase inhibitor, imidazole salycilate, in reducing airway hyperresponsiveness to methacholine in asthmatics.
    Peccini F; Dottorini ML; Casucci G; Mezzasoma AM; Sorbini CA; Tantucci C
    Monaldi Arch Chest Dis; 1997 Apr; 52(2):130-7. PubMed ID: 9203809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of short-term effect of the thromboxane synthetase inhibitor UK-38,485 on airway reactivity to methacholine in asthmatic subjects.
    Gardiner PV; Young CL; Holmes K; Hendrick DJ; Walters EH
    Eur Respir J; 1993 Jul; 6(7):1027-30. PubMed ID: 8370428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GR32191 and the role of thromboxane A2 in asthma--preclinical and clinical findings.
    Coleman RA
    Agents Actions Suppl; 1991; 34():211-20. PubMed ID: 1793065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma.
    Fujimura M; Sakamoto S; Saito M; Miyake Y; Matsuda T
    J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):23-7. PubMed ID: 1825100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of the prolonged action in man of GR32191, a thromboxane receptor antagonist.
    Ritter JM; Doktor HS; Benjamin N; Barrow SE; Stewart-Long P
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():351-4. PubMed ID: 1825568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction.
    Beasley RC; Featherstone RL; Church MK; Rafferty P; Varley JG; Harris A; Robinson C; Holgate ST
    J Appl Physiol (1985); 1989 Apr; 66(4):1685-93. PubMed ID: 2525122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuating effect of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to methacholine is specific to bronchial asthma.
    Fujimura M; Sakamoto S; Matsuda T
    Chest; 1990 Sep; 98(3):656-60. PubMed ID: 2203618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thromboxane A2 synthase inhibitor and receptor antagonist].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1986-91. PubMed ID: 11676143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Placebo-controlled study of subjects sensitized to toluene diisocyanate.
    Maestrelli P; De Marzo N; Saetta M; Boscaro M; Fabbri LM; Mapp CE
    Am Rev Respir Dis; 1993 Aug; 148(2):407-12. PubMed ID: 8393638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of thromboxane A2 in bronchial hyperresponsiveness of asthma. Kanazawa Asthma Research Group.
    Fujimura M; Nakatsumi Y; Nishi K; Kasahara K; Matsuda T
    Pulm Pharmacol; 1995 Dec; 8(6):251-7. PubMed ID: 8819179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary assessment of a novel thromboxane A2 receptor-blocking drug, GR32191, in healthy subjects.
    Thomas M; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I53-8; discussion I59-60. PubMed ID: 2136818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways.
    Stenton SC; Ward C; Duddridge M; Harris A; Palmer JB; Hendrick DJ; Walters EH
    Clin Exp Allergy; 1990 May; 20(3):311-7. PubMed ID: 2142013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboxane A2 receptor antagonist in asthma therapy].
    Endo S; Akiyama K
    Nihon Rinsho; 1996 Nov; 54(11):3045-8. PubMed ID: 8950952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics.
    Aizawa H; Shigyo M; Nogami H; Hirose T; Hara N
    Chest; 1996 Feb; 109(2):338-42. PubMed ID: 8620702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma.
    Fujimura M; Sakamoto S; Kamio Y; Matsuda T
    Respir Med; 1993 Feb; 87(2):133-8. PubMed ID: 8497683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics.
    Aizawa H; Inoue H; Nakano H; Matsumoto K; Yoshida M; Fukuyama S; Koto H; Hara N
    Prostaglandins Leukot Essent Fatty Acids; 1998 Sep; 59(3):185-90. PubMed ID: 9844991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis.
    Spurney RF; Fan PY; Ruiz P; Sanfilippo F; Pisetsky DS; Coffman TM
    Kidney Int; 1992 Apr; 41(4):973-82. PubMed ID: 1387435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.